PONVORY DIN 02515474
Health Canada record
| Active ingredient(s) | PONESIMOD 2 MG; PONESIMOD 3 MG; PONESIMOD 4 MG; PONESIMOD 5 MG; PONESIMOD 6 MG; PONESIMOD 7 MG; PONESIMOD 8 MG; PONESIMOD 9 MG; PONESIMOD 10 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L04AE04 PONESIMOD |
| Original market date | 01-Nov-2021 |
| Current status date | 27-Aug-2025 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PONESIMOD
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02515482 | PONVORY | VANDA PHARMACEUTICALS INC. | Tablet | PONESIMOD 20 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35894 | 2025-08-25 | New Drug Submission (NDS) | Administrative: Change in product ownership |
| 25744 | 2021-04-28 | New Drug Submission (NDS) |